Sionna Therapeutics (SION) Current Leases (2024 - 2026)

Quarterly results put Current Leases at $1.3 million for Q1 2026, up 18.14% from a year ago — trailing twelve months through Mar 2026 was $1.3 million (up 18.14% YoY), and the annual figure for FY2025 was $1.3 million, up 18.38%.

Sionna Therapeutics has reported Current Leases over the past 3 years, most recently at $1.3 million for Q1 2026.

  • Current Leases reached $1.3 million in Q1 2026 per SION's latest filing, up from $1.3 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.3 million in Q1 2026 and bottomed at $1.1 million in Q4 2024.
  • Median Current Leases over the past 3 years was $1.2 million (2025), compared with a mean of $1.2 million.
  • The largest annual shift saw Current Leases increased 18.38% in 2025 before it grew 18.14% in 2026.
  • Over 3 years, Current Leases stood at $1.1 million in 2024, then grew by 18.38% to $1.3 million in 2025, then grew by 4.18% to $1.3 million in 2026.
  • Business Quant data shows Current Leases for SION at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 83,991.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 720.00 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 45.66 Mn
10 Sionna Therapeutics 1.87 Bn 1.87 Bn - 1.32 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.32 Mn
Dec 31, 2025 1.27 Mn
Sep 30, 2025 1.22 Mn
Jun 30, 2025 1.17 Mn
Mar 31, 2025 1.12 Mn
Dec 31, 2024 1.07 Mn